Tyrosine Kinase 2 Inhibitor [EPC]

Tyrosine Kinase 2 Inhibitor [EPC] was reported 2976 times

Drugs of the Tyrosine Kinase 2 Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 ALPHA-2 MACROGLOBULIN INCREASED 1 0.1667
1 GALLBLADDER CANCER RECURRENT 1 0.1000
2 ORAL PURPURA 1 0.0909
3 FOLLICULITIS GENITAL 1 0.0769
4 CONJUNCTIVAL MELANOMA 1 0.0588
5 PSORIASIS AREA SEVERITY INDEX INCREASED 7 0.0424
6 TOXOCARIASIS 1 0.0250
7 ANAL BLISTER 1 0.0250
8 OLFACTORY DYSFUNCTION 1 0.0238
9 FATTY LIVER ALCOHOLIC 1 0.0172
10 CYCLOSPORIDIUM INFECTION 1 0.0169
11 CARDIOMYOPATHY ALCOHOLIC 1 0.0167
12 OCULAR CYST 1 0.0135
13 SPONDYLITIC MYELOPATHY 1 0.0125
14 HYPOPHARYNGEAL CANCER 1 0.0119
15 COUGH VARIANT ASTHMA 1 0.0119
16 BENIGN GASTRIC NEOPLASM 1 0.0119
17 HEPATITIS D 1 0.0119
18 ANGIODERMATITIS 1 0.0118
19 ANAL RASH 1 0.0104
20 GINGIVAL CANCER 1 0.0104
21 INFLAMMATORY PAIN 7 0.0103
22 ACNE FULMINANS 2 0.0102
23 INFECTIOUS THYROIDITIS 1 0.0098
24 POEMS SYNDROME 1 0.0095
25 FEMORAL HERNIA 1 0.0093
26 EXTERNAL EAR DISORDER 1 0.0089
27 RETROPERITONEAL ABSCESS 1 0.0083
28 ANAESTHESIA 3 0.0082
29 LACRIMATION DISORDER 1 0.0082
30 SOLAR URTICARIA 1 0.0079
31 BRONCHOMALACIA 1 0.0076
32 GENITAL DISORDER 1 0.0075
33 MALIGNANT NEOPLASM OF RENAL PELVIS 1 0.0073
34 TRICHOMONIASIS 1 0.0069
35 BLOOD BETA-D-GLUCAN INCREASED 2 0.0065
36 FOLLICULITIS 67 0.0064
37 COLORECTAL ADENOMA 2 0.0062
38 INTERFERON GAMMA RELEASE ASSAY POSITIVE 1 0.0061
39 URINARY RETENTION POSTOPERATIVE 1 0.0061
40 CORONAVIRUS PNEUMONIA 1 0.0060
41 EYELID BLEEDING 1 0.0058
42 SUBCHORIONIC HAEMATOMA 1 0.0057
43 PALMOPLANTAR PUSTULOSIS 3 0.0057
44 PHARYNGEAL CANCER 1 0.0056
45 BIOPSY SKIN 1 0.0056
46 BLOOD INSULIN ABNORMAL 1 0.0053
47 CHEST WALL ABSCESS 1 0.0051
48 HERPES SIMPLEX TEST POSITIVE 1 0.0050
49 UROGENITAL DISORDER 1 0.0050
50 ACUTE CHOLECYSTITIS NECROTIC 1 0.0050
51 NASAL HERPES 1 0.0049
52 ACNE PUSTULAR 4 0.0049
53 ELECTROCARDIOGRAM PR SHORTENED 1 0.0048
54 SKIN STRIAE 7 0.0047
55 KL-6 INCREASED 1 0.0044
56 SWEAT GLAND TUMOUR 1 0.0043
57 PUSTULE 10 0.0042
58 PILONIDAL DISEASE 1 0.0042
59 TONGUE GEOGRAPHIC 1 0.0040
60 SQUAMOUS CELL CARCINOMA OF LUNG 3 0.0039
61 PHARYNGITIS BACTERIAL 1 0.0039
62 EXPOSURE TO CONTAMINATED DEVICE 1 0.0038
63 PUSTULAR PSORIASIS 13 0.0038
64 LOSS OF THERAPEUTIC RESPONSE 12 0.0038
65 APHTHOUS ULCER 29 0.0037
66 PERIORBITAL CELLULITIS 2 0.0037
67 ECZEMA INFECTED 1 0.0037
68 PERIPHERAL PARALYSIS 1 0.0037
69 SACROILIITIS 7 0.0037
70 MALIGNANT MELANOMA STAGE I 1 0.0037
71 ACNE CYSTIC 11 0.0036
72 ERYTHRODERMIC PSORIASIS 3 0.0036
73 MOUTH ULCERATION 76 0.0036
74 METASTASES TO NECK 1 0.0036
75 HEPATITIS A 3 0.0035
76 EYE ULCER 2 0.0035
77 ACNE 255 0.0034
78 EAR INFECTION FUNGAL 1 0.0033
79 GASTROENTERITIS CLOSTRIDIAL 1 0.0028
80 TINEA VERSICOLOUR 1 0.0028
81 TRANCE 1 0.0027
82 DIABETIC GASTROPARESIS 1 0.0027
83 THERAPEUTIC PRODUCT EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0027
84 HEPATITIS B VIRUS TEST POSITIVE 1 0.0026
85 HERPES SIMPLEX REACTIVATION 1 0.0026
86 CENTRAL NERVOUS SYSTEM INFECTION 3 0.0026
87 DIVERTICULITIS INTESTINAL HAEMORRHAGIC 1 0.0026
88 BREAST SWELLING 7 0.0026
89 CAPILLARY DISORDER 1 0.0026
90 SINONASAL OBSTRUCTION 1 0.0025
91 VIRAL PHARYNGITIS 1 0.0025
92 VAGINAL ULCERATION 1 0.0024
93 PHOTODERMATOSIS 1 0.0024
94 DERMATITIS EXFOLIATIVE GENERALISED 8 0.0023
95 VULVOVAGINAL RASH 1 0.0023
96 MACULE 6 0.0022
97 ECZEMA HERPETICUM 1 0.0022
98 ROSACEA 10 0.0021
99 DERMATITIS ACNEIFORM 13 0.0021
100 TONGUE ERUPTION 1 0.0020
101 HERPES ZOSTER OTICUS 1 0.0020
102 METASTATIC SQUAMOUS CELL CARCINOMA 1 0.0020
103 SPONDYLITIS 7 0.0019
104 ABDOMINAL INJURY 1 0.0019
105 URETHRITIS 1 0.0018
106 INTERTRIGO 1 0.0018
107 GROIN INFECTION 1 0.0018
108 ORAL HERPES 35 0.0018
109 BODY TINEA 1 0.0018
110 OPHTHALMIC HERPES SIMPLEX 1 0.0017
111 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 4 0.0017
112 ALLERGY TO METALS 1 0.0016
113 SPONTANEOUS PENILE ERECTION 1 0.0016
114 PERIORAL DERMATITIS 1 0.0016
115 INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE 1 0.0016
116 GLIOMA 1 0.0016
117 STAPHYLOCOCCAL ABSCESS 1 0.0016
118 SPINAL CORD INFECTION 1 0.0015
119 PHARYNGEAL ULCERATION 2 0.0015
120 TONGUE ULCERATION 5 0.0015
121 ORAL PAIN 33 0.0015
122 CENTRAL SEROUS CHORIORETINOPATHY 1 0.0015
123 PSORIASIS 190 0.0015
124 POSITRON EMISSION TOMOGRAM ABNORMAL 1 0.0014
125 GENITAL RASH 2 0.0014
126 DYSHIDROTIC ECZEMA 1 0.0014
127 HERPES SIMPLEX 9 0.0014
128 LABELLED DRUG-DRUG INTERACTION ISSUE 2 0.0014
129 BRONCHITIS BACTERIAL 1 0.0013
130 DIZZINESS EXERTIONAL 1 0.0013
131 CONTRAINDICATION TO MEDICAL TREATMENT 2 0.0013
132 GENITAL HERPES 2 0.0013
133 TRACHEOBRONCHITIS 1 0.0013
134 CREATINE KINASE INCREASED 1 0.0013
135 GENITAL ULCERATION 1 0.0013
136 LICHEN PLANUS 3 0.0013
137 MYCOPLASMA INFECTION 1 0.0013
138 METAPNEUMOVIRUS INFECTION 1 0.0013
139 VITAMIN B12 INCREASED 1 0.0013
140 NASAL ULCER 2 0.0013
141 LIP ERYTHEMA 1 0.0013
142 PELVIC MASS 1 0.0012
143 SKIN BURNING SENSATION 88 0.0012
144 GUTTATE PSORIASIS 1 0.0012
145 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 1 0.0012
146 GLOMERULAR FILTRATION RATE INCREASED 1 0.0012
147 SEBORRHOEIC DERMATITIS 2 0.0012
148 GIANT CELL ARTERITIS 1 0.0012
149 VULVOVAGINAL ERYTHEMA 1 0.0012
150 PERITONSILLAR ABSCESS 1 0.0012
151 SOLILOQUY 1 0.0012
152 ALCOHOL WITHDRAWAL SYNDROME 1 0.0011
153 OTORRHOEA 2 0.0011
154 NON-SMALL CELL LUNG CANCER METASTATIC 1 0.0011
155 ANOGENITAL WARTS 1 0.0011
156 SALIVA ALTERED 1 0.0011
157 MUCOSAL EROSION 1 0.0011
158 PRODUCT AFTER TASTE 1 0.0010
159 SKIN TEXTURE ABNORMAL 1 0.0010
160 VAGINAL DISORDER 1 0.0010
161 LUNG CANCER METASTATIC 3 0.0010
162 DACTYLITIS 1 0.0010
163 BLOOD TRIGLYCERIDES INCREASED 18 0.0010
164 MUCOSAL DISORDER 1 0.0010
165 BUTTERFLY RASH 1 0.0010
166 LIGHT CHAIN ANALYSIS INCREASED 1 0.0010
167 LATENT TUBERCULOSIS 2 0.0010
168 NON-CARDIOGENIC PULMONARY OEDEMA 1 0.0009
169 EAR SWELLING 2 0.0009
170 SKIN DISORDER 31 0.0009
171 PEMPHIGOID 7 0.0009
172 TONGUE BLISTERING 2 0.0009
173 RHEUMATOID FACTOR INCREASED 1 0.0009
174 ADVERSE EVENT 82 0.0009
175 HALO VISION 1 0.0009
176 HYPERSENSITIVITY PNEUMONITIS 1 0.0009
177 PRODUCT DISTRIBUTION ISSUE 8 0.0009
178 SMALL INTESTINAL RESECTION 1 0.0009
179 LIP ULCERATION 1 0.0009
180 FULL BLOOD COUNT INCREASED 1 0.0008
181 BRONCHIAL HYPERREACTIVITY 1 0.0008
182 ERYTHEMA 171 0.0008
183 STAPHYLOCOCCAL SKIN INFECTION 1 0.0008
184 CUTANEOUS T-CELL LYMPHOMA 1 0.0008
185 HYPERAESTHESIA TEETH 1 0.0008
186 TESTICULAR SWELLING 1 0.0008
187 DERMATOMYOSITIS 2 0.0008
188 LIP INJURY 1 0.0008
189 LIP EXFOLIATION 1 0.0008
190 FUNGAL SKIN INFECTION 3 0.0007
191 LIP BLISTER 2 0.0007
192 PSORIATIC ARTHROPATHY 29 0.0007
193 ATYPICAL MYCOBACTERIAL INFECTION 1 0.0007
194 RESPIRATORY SYMPTOM 2 0.0007
195 MENINGITIS BACTERIAL 1 0.0007
196 POST HERPETIC NEURALGIA 1 0.0007
197 HERPES VIRUS INFECTION 4 0.0007
198 NONINFECTIVE GINGIVITIS 1 0.0007
199 UPPER RESPIRATORY TRACT CONGESTION 2 0.0007
200 PULMONARY SEPSIS 1 0.0007
201 PREGNANCY ON CONTRACEPTIVE 1 0.0007
202 RED BLOOD CELL COUNT ABNORMAL 1 0.0007
203 GINGIVAL SWELLING 3 0.0007
204 STEROID DIABETES 1 0.0007
205 STOMATITIS 40 0.0007
206 AGE-RELATED MACULAR DEGENERATION 1 0.0007
207 INSURANCE ISSUE 10 0.0007
208 PNEUMONIA PSEUDOMONAL 1 0.0007
209 CALCULUS URINARY 1 0.0006
210 ORAL MUCOSAL ERYTHEMA 1 0.0006
211 MYELITIS 1 0.0006
212 BACTERIAL VAGINOSIS 1 0.0006
213 SWELLING OF EYELID 4 0.0006
214 PRURITUS 244 0.0006
215 HEPATITIS E 1 0.0006
216 BILE DUCT STONE 2 0.0006
217 RASH VESICULAR 3 0.0006
218 ACUTE LEUKAEMIA 1 0.0006
219 PHARYNGEAL SWELLING 6 0.0006
220 PAPILLOMA VIRAL INFECTION 1 0.0006
221 THERAPY INTERRUPTED 43 0.0006
222 VEIN RUPTURE 1 0.0006
223 SKIN PLAQUE 5 0.0006
224 FACIAL PARALYSIS 5 0.0006
225 BENIGN PROSTATIC HYPERPLASIA 3 0.0006
226 PANCREATIC FAILURE 1 0.0006
227 THERAPY NON-RESPONDER 25 0.0006
228 BURNING SENSATION 39 0.0006
229 OPHTHALMIC HERPES ZOSTER 1 0.0006
230 CHEILITIS 3 0.0006
231 VULVOVAGINAL SWELLING 1 0.0005
232 ESSENTIAL HYPERTENSION 1 0.0005
233 DRUG EFFECT LESS THAN EXPECTED 8 0.0005
234 STREPTOCOCCAL INFECTION 3 0.0005
235 ERYTHEMA MULTIFORME 5 0.0005
236 LUPUS NEPHRITIS 1 0.0005
237 NASAL OBSTRUCTION 1 0.0005
238 PARANASAL SINUS DISCOMFORT 2 0.0005
239 MENOMETRORRHAGIA 1 0.0005
240 MOUTH SWELLING 3 0.0005
241 NASAL SEPTUM DEVIATION 1 0.0005
242 FURUNCLE 4 0.0005
243 GINGIVAL PAIN 4 0.0005
244 ANORECTAL DISORDER 1 0.0005
245 SQUAMOUS CELL CARCINOMA OF SKIN 3 0.0005
246 DEVICE RELATED SEPSIS 1 0.0005
247 LIPIDS INCREASED 1 0.0005
248 PRODUCT DOSE OMISSION IN ERROR 14 0.0005
249 RENAL HAEMORRHAGE 1 0.0005
250 DERMATITIS PSORIASIFORM 1 0.0005
251 HERPES ZOSTER 28 0.0005
252 RASH 206 0.0005
253 MUSCLE FATIGUE 2 0.0005
254 COLON CANCER 7 0.0005
255 POOR PERIPHERAL CIRCULATION 2 0.0005
256 ABSCESS LIMB 2 0.0005
257 MEDICAL DEVICE PAIN 1 0.0005
258 LANGUAGE DISORDER 1 0.0005
259 CHAPPED LIPS 2 0.0005
260 DIVERTICULUM INTESTINAL 2 0.0005
261 LIMB MASS 1 0.0005
262 ENDOMETRIAL CANCER 1 0.0005
263 DANDRUFF 1 0.0005
264 BLOOD CREATINE PHOSPHOKINASE INCREASED 13 0.0005
265 RHINITIS ALLERGIC 2 0.0004
266 MENINGITIS 3 0.0004
267 ADENOCARCINOMA 1 0.0004
268 CHROMATURIA 10 0.0004
269 GENERAL PHYSICAL CONDITION ABNORMAL 3 0.0004
270 THERAPEUTIC PRODUCT EFFECT DELAYED 2 0.0004
271 EAR DISORDER 2 0.0004
272 UPPER RESPIRATORY TRACT INFECTION 20 0.0004
273 FLAT AFFECT 1 0.0004
274 UTERINE DISORDER 1 0.0004
275 VITILIGO 1 0.0004
276 PRURITUS GENITAL 1 0.0004
277 THERMAL BURN 3 0.0004
278 INTRA-ABDOMINAL HAEMORRHAGE 1 0.0004
279 VARICELLA 1 0.0004
280 SUBCUTANEOUS ABSCESS 2 0.0004
281 WEIGHT ABNORMAL 1 0.0004
282 SWELLING FACE 27 0.0004
283 EAR PAIN 8 0.0004
284 ORAL DISORDER 3 0.0004
285 JUVENILE IDIOPATHIC ARTHRITIS 1 0.0004
286 DERMAL CYST 1 0.0004
287 TOOTH DISORDER 9 0.0004
288 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
289 PHARYNGITIS 5 0.0004
290 INABILITY TO AFFORD MEDICATION 4 0.0004
291 EYELID IRRITATION 1 0.0004
292 TUBERCULIN TEST POSITIVE 1 0.0004
293 VULVOVAGINAL PRURITUS 2 0.0004
294 ABDOMINAL INFECTION 1 0.0004
295 OROPHARYNGEAL PAIN 36 0.0004
296 PHYSICAL DECONDITIONING 1 0.0004
297 LOW DENSITY LIPOPROTEIN INCREASED 3 0.0004
298 TREATMENT NONCOMPLIANCE 21 0.0004
299 PRODUCT PACKAGING DIFFICULT TO OPEN 1 0.0004
300 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
301 LUNG OPACITY 1 0.0004
302 NASAL DISORDER 1 0.0004
303 YAWNING 1 0.0004
304 FOOD POISONING 2 0.0004
305 ABDOMINAL MASS 1 0.0004
306 MYCOBACTERIUM AVIUM COMPLEX INFECTION 1 0.0004
307 RASH MACULAR 13 0.0004
308 GINGIVITIS 2 0.0004
309 SKIN DISCOMFORT 1 0.0004
310 PHARYNGITIS STREPTOCOCCAL 4 0.0004
311 EAR CONGESTION 1 0.0004
312 ORAL FUNGAL INFECTION 1 0.0004
313 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
314 RHINALGIA 1 0.0004
315 DEAFNESS UNILATERAL 2 0.0004
316 ORAL DISCOMFORT 5 0.0004
317 EYE INFECTION 4 0.0004
318 DERMATITIS CONTACT 4 0.0004
319 LIP PAIN 1 0.0003
320 RETINAL VEIN OCCLUSION 1 0.0003
321 SKIN ATROPHY 2 0.0003
322 HYPERTONIC BLADDER 1 0.0003
323 LUMBAR SPINAL STENOSIS 1 0.0003
324 STRIDOR 1 0.0003
325 EAR INFECTION 9 0.0003
326 HIV INFECTION 1 0.0003
327 LIP SWELLING 11 0.0003
328 LIVER FUNCTION TEST INCREASED 7 0.0003
329 RECTAL CANCER 1 0.0003
330 PIGMENTATION DISORDER 2 0.0003
331 LYMPHOMA 5 0.0003
332 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 23 0.0003
333 MULTIPLE-DRUG RESISTANCE 1 0.0003
334 URTICARIA 54 0.0003
335 PRODUCT DISPENSING ERROR 7 0.0003
336 EYELIDS PRURITUS 1 0.0003
337 DERMATITIS ALLERGIC 4 0.0003
338 IRIDOCYCLITIS 1 0.0003
339 RESPIRATORY TRACT CONGESTION 5 0.0003
340 SKIN EROSION 1 0.0003
341 SKIN FISSURES 6 0.0003
342 ARTHROPATHY 17 0.0003
343 SUSPECTED COVID-19 1 0.0003
344 BLISTER 17 0.0003
345 OTITIS MEDIA 1 0.0003
346 CORONAVIRUS INFECTION 2 0.0003
347 ADVERSE REACTION 4 0.0003
348 HIGH DENSITY LIPOPROTEIN DECREASED 1 0.0003
349 SKIN MASS 2 0.0003
350 THERAPEUTIC RESPONSE DECREASED 18 0.0003
351 CANDIDA INFECTION 5 0.0003
352 UVEITIS 4 0.0003
353 SKIN LESION 8 0.0003
354 ONYCHOCLASIS 2 0.0003
355 GRANULOMA 1 0.0003
356 DEPRESSION SUICIDAL 1 0.0003
357 LARGE INTESTINE POLYP 2 0.0003
358 PAPULE 2 0.0003
359 NECROTISING FASCIITIS 1 0.0003
360 FACIAL PARESIS 1 0.0003
361 PRODUCT DOSE OMISSION ISSUE 83 0.0003
362 ILLNESS 29 0.0003
363 PRODUCT CONTAMINATION 1 0.0003
364 TONGUE DISORDER 2 0.0003
365 DERMATITIS BULLOUS 2 0.0003
366 PRODUCT PRESCRIBING ISSUE 6 0.0003
367 MOUTH HAEMORRHAGE 2 0.0003
368 SEBORRHOEA 1 0.0003
369 SKIN ULCER 7 0.0003
370 WOUND HAEMORRHAGE 1 0.0003
371 SKIN HAEMORRHAGE 4 0.0003
372 EYE SWELLING 10 0.0003
373 HYPERACUSIS 1 0.0003
374 IMMUNODEFICIENCY 4 0.0003
375 SUNBURN 2 0.0003
376 SKIN INFECTION 3 0.0003
377 THROAT CLEARING 1 0.0003
378 PRODUCT STORAGE ISSUE 1 0.0003
379 BOWEL MOVEMENT IRREGULARITY 2 0.0003
380 THYROID MASS 1 0.0003
381 OESOPHAGEAL ULCER 1 0.0003
382 THERAPEUTIC PRODUCT INEFFECTIVE 1 0.0003
383 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
384 MUSCLE RUPTURE 1 0.0003
385 BRAIN FOG 4 0.0003
386 SINUSITIS 26 0.0003
387 RASH ERYTHEMATOUS 12 0.0003
388 SKIN PAPILLOMA 1 0.0002
389 INTRACRANIAL ANEURYSM 1 0.0002
390 ARTHRITIS BACTERIAL 1 0.0002
391 HYPERURICAEMIA 1 0.0002
392 ANAPHYLACTOID REACTION 1 0.0002
393 PHOTOSENSITIVITY REACTION 4 0.0002
394 CYST 3 0.0002
395 THYROID FUNCTION TEST ABNORMAL 1 0.0002
396 SLEEP TERROR 1 0.0002
397 SKIN EXFOLIATION 20 0.0002
398 TONGUE DISCOMFORT 1 0.0002
399 UTERINE HAEMORRHAGE 1 0.0002
400 SKIN HYPERPIGMENTATION 2 0.0002
401 MYOPATHY 2 0.0002
402 HEPATIC LESION 1 0.0002
403 HORDEOLUM 1 0.0002
404 RESPIRATORY TRACT INFECTION 6 0.0002
405 DISCOMFORT 14 0.0002
406 ECZEMA 12 0.0002
407 TONGUE DISCOLOURATION 1 0.0002
408 ONYCHOMYCOSIS 1 0.0002
409 IMMUNE SYSTEM DISORDER 3 0.0002
410 GRIP STRENGTH DECREASED 2 0.0002
411 LYMPHADENOPATHY 8 0.0002
412 BLOOD CREATINE INCREASED 1 0.0002
413 LIVER DISORDER 10 0.0002
414 BRAIN NEOPLASM MALIGNANT 1 0.0002
415 RASH PAPULAR 5 0.0002
416 TOOTHACHE 4 0.0002
417 LIP DRY 2 0.0002
418 HIDRADENITIS 2 0.0002
419 CELLULITIS 11 0.0002
420 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
421 DRUG INEFFECTIVE 286 0.0002
422 BLOOD GLUCOSE ABNORMAL 4 0.0002
423 RHABDOMYOLYSIS 9 0.0002
424 RENAL FUNCTION TEST ABNORMAL 1 0.0002
425 MASS 3 0.0002
426 GASTRITIS EROSIVE 1 0.0002
427 FEELING OF DESPAIR 1 0.0002
428 RENAL IMPAIRMENT 18 0.0002
429 YELLOW SKIN 1 0.0002
430 VAGINAL INFECTION 1 0.0002
431 PRE-ECLAMPSIA 1 0.0002
432 HYPERSENSITIVITY 39 0.0002
433 PARAESTHESIA ORAL 3 0.0002
434 NASOPHARYNGITIS 38 0.0002
435 COVID-19 36 0.0002
436 AUTOIMMUNE DISORDER 2 0.0002
437 RENAL CELL CARCINOMA 1 0.0002
438 KIDNEY INFECTION 4 0.0002
439 THERAPY CHANGE 2 0.0002
440 NASAL POLYPS 1 0.0002
441 RASH PRURITIC 11 0.0002
442 PANCREATIC DISORDER 1 0.0002
443 SINUS DISORDER 4 0.0002
444 PULMONARY MASS 3 0.0002
445 PROTEIN URINE PRESENT 1 0.0002
446 THERAPEUTIC RESPONSE UNEXPECTED 9 0.0002
447 MYALGIA 34 0.0002
448 DERMATITIS EXFOLIATIVE 1 0.0002
449 ENDOCARDITIS 1 0.0002
450 INITIAL INSOMNIA 2 0.0002
451 SKIN NECROSIS 1 0.0002
452 PERIORBITAL OEDEMA 1 0.0002
453 SWOLLEN TONGUE 6 0.0002
454 TENDERNESS 2 0.0002
455 ARTHRITIS 15 0.0002
456 FOOD CRAVING 1 0.0002
457 COMPRESSION FRACTURE 1 0.0002
458 INJECTION SITE DISCHARGE 1 0.0002
459 SKIN CANCER 4 0.0002
460 ANAL ABSCESS 1 0.0002
461 THROAT TIGHTNESS 5 0.0002
462 HIP SURGERY 1 0.0002
463 WOUND INFECTION 2 0.0002
464 ASTHENOPIA 1 0.0002
465 AUTISM SPECTRUM DISORDER 1 0.0002
466 TREATMENT FAILURE 15 0.0002
467 THERAPEUTIC RESPONSE SHORTENED 6 0.0002
468 VIRAL INFECTION 6 0.0002
469 GLOSSODYNIA 4 0.0002
470 THERAPEUTIC PRODUCT EFFECT DECREASED 8 0.0002
471 SNEEZING 4 0.0002
472 REBOUND EFFECT 2 0.0002
473 PERIORBITAL SWELLING 1 0.0002
474 CHOLECYSTITIS ACUTE 1 0.0002
475 PERONEAL NERVE PALSY 1 0.0002
476 MYOCARDIAL ISCHAEMIA 2 0.0002
477 SCAB 2 0.0002
478 THERAPY CESSATION 9 0.0002
479 MUSCULOSKELETAL DISCOMFORT 3 0.0002
480 GASTRIC HAEMORRHAGE 2 0.0002
481 ENTEROCOLITIS 1 0.0002
482 BLOOD URIC ACID INCREASED 1 0.0002
483 HYPERCHLORHYDRIA 1 0.0002
484 ENERGY INCREASED 1 0.0002
485 BRADYKINESIA 1 0.0002
486 COVID-19 PNEUMONIA 2 0.0002
487 DRUG ERUPTION 3 0.0002
488 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
489 GALLBLADDER DISORDER 3 0.0002
490 ODYNOPHAGIA 1 0.0002
491 GASTROINTESTINAL DISORDER 15 0.0002
492 RESPIRATORY DISORDER 5 0.0002
493 ADVERSE DRUG REACTION 15 0.0002
494 GANGRENE 1 0.0002
495 HEPATITIS B 1 0.0002
496 INJECTION SITE VESICLES 1 0.0002
497 CONTRAINDICATED PRODUCT ADMINISTERED 5 0.0002
498 PRODUCT USE ISSUE 31 0.0002
499 INGUINAL HERNIA 1 0.0002
500 PERIPHERAL SWELLING 25 0.0002
501 LARYNGEAL OEDEMA 1 0.0002
502 CONJUNCTIVITIS 3 0.0002
503 SCOLIOSIS 1 0.0002
504 CHOLANGITIS 1 0.0002
505 HEPATIC CIRRHOSIS 3 0.0002
506 NASAL DRYNESS 1 0.0002
507 PHOTOPHOBIA 3 0.0002
508 BLEPHAROSPASM 1 0.0002
509 CARDIOVASCULAR DISORDER 4 0.0002
510 FOREIGN BODY SENSATION IN EYES 1 0.0002
511 CARDIAC FLUTTER 1 0.0002
512 INFECTION 22 0.0002
513 ANKYLOSING SPONDYLITIS 2 0.0002
514 STAPHYLOCOCCAL INFECTION 5 0.0002
515 APPETITE DISORDER 1 0.0002
516 FUNGAL INFECTION 5 0.0001
517 EYE PRURITUS 5 0.0001
518 POSTOPERATIVE WOUND INFECTION 1 0.0001
519 SINUS CONGESTION 2 0.0001
520 TASTE DISORDER 3 0.0001
521 ULCER HAEMORRHAGE 1 0.0001
522 INFARCTION 1 0.0001
523 INFLUENZA LIKE ILLNESS 12 0.0001
524 LYMPHOEDEMA 1 0.0001
525 ENCEPHALITIS 1 0.0001
526 MENTAL STATUS CHANGES 4 0.0001
527 FORMICATION 1 0.0001
528 DERMATITIS 3 0.0001
529 DEMENTIA 4 0.0001
530 PULMONARY TOXICITY 1 0.0001
531 SEASONAL ALLERGY 2 0.0001
532 HAND FRACTURE 1 0.0001
533 SYSTEMIC LUPUS ERYTHEMATOSUS 5 0.0001
534 DIVERTICULUM 1 0.0001
535 IMPAIRED WORK ABILITY 3 0.0001
536 PRODUCT SUPPLY ISSUE 1 0.0001
537 CONDITION AGGRAVATED 42 0.0001
538 RASH PUSTULAR 1 0.0001
539 OFF LABEL USE 120 0.0001
540 INFLAMMATION 7 0.0001
541 SENSITIVE SKIN 1 0.0001
542 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
543 BRONCHITIS 10 0.0001
544 ARTHROPOD BITE 1 0.0001
545 INFLUENZA 15 0.0001
546 PAROSMIA 1 0.0001
547 SKIN IRRITATION 6 0.0001
548 NEPHROLITHIASIS 6 0.0001
549 HEADACHE 82 0.0001
550 DEVICE RELATED INFECTION 2 0.0001
551 THYROID DISORDER 2 0.0001
552 BLOOD CHOLESTEROL INCREASED 6 0.0001
553 PAIN 79 0.0001
554 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 7 0.0001
555 AFFECTIVE DISORDER 1 0.0001
556 PRODUCT USE COMPLAINT 2 0.0001
557 NASAL DISCOMFORT 1 0.0001
558 ULCER 2 0.0001
559 CYSTITIS 4 0.0001
560 UTERINE CANCER 1 0.0001
561 LOCALISED INFECTION 3 0.0001
562 RHINITIS 1 0.0001
563 MUSCLE DISORDER 1 0.0001
564 BLOOD POTASSIUM INCREASED 2 0.0001
565 BACK DISORDER 2 0.0001
566 POST PROCEDURAL INFECTION 1 0.0001
567 CEREBRAL INFARCTION 3 0.0001
568 HYPERAESTHESIA 1 0.0001
569 ESCHERICHIA INFECTION 1 0.0001
570 HAIR DISORDER 1 0.0001
571 MENSTRUAL DISORDER 1 0.0001
572 EMBOLISM 1 0.0001
573 HEMIPLEGIA 1 0.0001
574 EOSINOPHIL COUNT INCREASED 1 0.0001
575 BLOOD UREA INCREASED 2 0.0001
576 GASTRIC CANCER 3 0.0001
577 URINARY TRACT INFECTION 20 0.0001
578 PYELONEPHRITIS 1 0.0001
579 SKIN SWELLING 1 0.0001
580 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
581 BLOOD CALCIUM INCREASED 1 0.0001
582 GROIN PAIN 1 0.0001
583 SPINAL OSTEOARTHRITIS 1 0.0001
584 DERMATITIS ATOPIC 6 0.0001
585 COLD SWEAT 2 0.0001
586 PRODUCT COMMUNICATION ISSUE 1 0.0001
587 ARTHRALGIA 47 0.0001
588 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
589 FACIAL PAIN 1 0.0001
590 GASTROINTESTINAL INFECTION 1 0.0001
591 THROAT IRRITATION 5 0.0001
592 PAIN OF SKIN 3 0.0001
593 HEAVY MENSTRUAL BLEEDING 1 0.0001
594 CHILLS 13 0.0001
595 GASTROENTERITIS VIRAL 2 0.0001
596 OROPHARYNGEAL DISCOMFORT 1 0.0001
597 MOOD ALTERED 3 0.0001
598 PYREXIA 38 0.0001
599 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
600 ABNORMAL DREAMS 3 0.0001
601 OVARIAN CANCER 1 0.0001
602 UROSEPSIS 1 0.0001
603 IRON DEFICIENCY ANAEMIA 1 0.0001
604 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
605 HAEMOPTYSIS 3 0.0001
606 WOUND 3 0.0001
607 BACTERIAL INFECTION 2 0.0001
608 APPENDICITIS 1 0.0001
609 FRACTURE 2 0.0001
610 SPINAL DISORDER 1 0.0001
611 BLOOD URINE PRESENT 2 0.0001
612 INTENTIONAL DOSE OMISSION 3 0.0001
613 MUSCULOSKELETAL DISORDER 2 0.0001
614 DIABETES MELLITUS 8 0.0001
615 NEOPLASM MALIGNANT 7 0.0001
616 HYPERSOMNIA 3 0.0001
617 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
618 PULMONARY FIBROSIS 2 0.0001
619 POST PROCEDURAL COMPLICATION 2 0.0001
620 PANCREATIC CARCINOMA 3 0.0001
621 DRUG INTOLERANCE 10 0.0001
622 INTERSTITIAL LUNG DISEASE 5 0.0001
623 INFLAMMATORY BOWEL DISEASE 1 0.0001
624 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
625 VITREOUS FLOATERS 1 0.0001
626 URINARY INCONTINENCE 3 0.0001
627 BLADDER DISORDER 1 0.0001
628 UPPER LIMB FRACTURE 2 0.0001
629 COUGH 28 0.0001
630 TOXIC SKIN ERUPTION 1 0.0001
631 MUSCLE SPASMS 18 0.0001
632 NEUTROPHIL COUNT INCREASED 1 0.0001
633 EAR DISCOMFORT 1 0.0001
634 EMOTIONAL DISORDER 3 0.0001
635 LIMB DISCOMFORT 3 0.0001
636 TEMPERATURE INTOLERANCE 1 0.0001
637 EYE DISCHARGE 1 0.0001
638 SWELLING 9 0.0001
639 DIARRHOEA 62 0.0001
640 PETECHIAE 1 0.0001
641 SCRATCH 1 0.0001
642 INCONTINENCE 1 0.0001
643 SUDDEN DEATH 1 0.0001
644 MIGRAINE 9 0.0001
645 EATING DISORDER 2 0.0001
646 BREAST PAIN 1 0.0001
647 HIP FRACTURE 3 0.0001
648 IRRITABLE BOWEL SYNDROME 2 0.0001
649 NIGHT SWEATS 3 0.0001
650 PNEUMONIA 30 0.0001
651 MENTAL DISORDER 4 0.0001
652 PULMONARY THROMBOSIS 1 0.0001
653 EYE DISORDER 3 0.0001
654 HOSPITALISATION 14 0.0001
655 ANGIOEDEMA 4 0.0001
656 FOOT DEFORMITY 1 0.0001
657 URINARY RETENTION 3 0.0001
658 DRY SKIN 12 0.0001
659 ABDOMINAL DISCOMFORT 15 0.0001
660 NEPHROPATHY TOXIC 1 0.0001
661 OCULAR DISCOMFORT 1 0.0001
662 MYOCARDITIS 1 0.0001
663 THROMBOSIS 7 0.0001
664 NEOPLASM 1 0.0001
665 EYE IRRITATION 5 0.0001
666 PALPITATIONS 10 0.0001
667 OCULAR HYPERAEMIA 4 0.0001
668 BLOOD IRON DECREASED 1 0.0001
669 ACCIDENT 1 0.0001
670 CONTUSION 8 0.0001
671 HEPATITIS C 1 0.0001
672 LUNG DISORDER 4 0.0001
673 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
674 SPINAL OPERATION 1 0.0001
675 TENDON RUPTURE 1 0.0001
676 OSTEONECROSIS OF JAW 2 0.0001
677 DRY EYE 4 0.0001
678 PEMPHIGUS 1 0.0001
679 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
680 ABDOMINAL PAIN LOWER 2 0.0001
681 MUSCLE ATROPHY 1 0.0001
682 MATERNAL EXPOSURE DURING PREGNANCY 7 0.0001
683 CHEST DISCOMFORT 8 0.0001
684 ABDOMINAL PAIN UPPER 16 0.0001
685 INFUSION SITE PAIN 1 0.0001
686 RHINORRHOEA 5 0.0001
687 HIATUS HERNIA 1 0.0001
688 DEEP VEIN THROMBOSIS 5 0.0001
689 PRODUCT USE IN UNAPPROVED INDICATION 19 0.0001
690 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
691 NODULE 1 0.0001
692 BLOOD CREATININE INCREASED 5 0.0001
693 DEAFNESS 2 0.0001
694 BEDRIDDEN 1 0.0001
695 ORAL CANDIDIASIS 1 0.0001
696 TOOTH INFECTION 1 0.0001
697 PULMONARY CONGESTION 1 0.0001
698 SARS-COV-2 TEST POSITIVE 1 0.0001
699 CARDIAC DISORDER 7 0.0001
700 MALIGNANT MELANOMA 1 0.0001
701 BLINDNESS 3 0.0001
702 CONSTIPATION 16 0.0001
703 GINGIVAL BLEEDING 1 0.0001
704 FATIGUE 57 0.0001
705 LUNG NEOPLASM MALIGNANT 3 0.0001
706 CORONARY ARTERY OCCLUSION 1 0.0001
707 PERIPHERAL COLDNESS 1 0.0001
708 PROSTATIC SPECIFIC ANTIGEN INCREASED 1 0.0001
709 DIVERTICULITIS 2 0.0001
710 SEPSIS 8 0.0001
711 NECK PAIN 4 0.0001
712 CARPAL TUNNEL SYNDROME 1 0.0001
713 SINUS TACHYCARDIA 1 0.0001
714 BRONCHOSPASM 1 0.0001
715 HYPOACUSIS 3 0.0001
716 HYPOKINESIA 1 0.0001
717 PRODUCT STORAGE ERROR 6 0.0001
718 GASTROENTERITIS 1 0.0001
719 NASAL CONGESTION 4 0.0001
720 DEHYDRATION 9 0.0001
721 OESOPHAGEAL CARCINOMA 2 0.0001
722 DYSGEUSIA 5 0.0001
723 COLITIS ULCERATIVE 3 0.0001
724 WEIGHT INCREASED 15 0.0001
725 BONE LOSS 1 0.0001
726 HYPOAESTHESIA ORAL 1 0.0001
727 ALOPECIA 13 0.0001
728 CORONARY ARTERY DISEASE 2 0.0001
729 VERTIGO 4 0.0001
730 BLOOD PRESSURE INCREASED 10 0.0001
731 SKIN DISCOLOURATION 3 0.0001
732 CEREBROVASCULAR ACCIDENT 11 0.0001
733 MUSCULOSKELETAL CHEST PAIN 1 0.0001
734 BACK PAIN 15 0.0001
735 RENAL DISORDER 3 0.0001
736 THERAPY PARTIAL RESPONDER 1 0.0001
737 BASAL CELL CARCINOMA 1 0.0001
738 NERVOUS SYSTEM DISORDER 2 0.0001
739 PARAESTHESIA 10 0.0001
740 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
741 PNEUMOTHORAX 1 0.0001
742 HALLUCINATION, AUDITORY 1 0.0001
743 PRODUCTIVE COUGH 3 0.0001
744 PREMATURE DELIVERY 1 0.0001
745 MOOD SWINGS 2 0.0001
746 ABSCESS 1 0.0001
747 MOVEMENT DISORDER 2 0.0001
748 MUSCLE TIGHTNESS 1 0.0001
749 MUSCULAR WEAKNESS 7 0.0001
750 NAUSEA 48 0.0001
751 DECREASED APPETITE 14 0.0001
752 EXPIRED PRODUCT ADMINISTERED 2 0.0001
753 FACE OEDEMA 1 0.0001
754 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
755 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
756 PARANOIA 1 0.0001
757 PAIN IN EXTREMITY 17 0.0001
758 WEIGHT DECREASED 16 0.0001
759 MUSCULOSKELETAL PAIN 3 0.0001
760 EOSINOPHILIA 1 0.0001
761 MALAISE 25 0.0001
762 HEART RATE DECREASED 2 0.0001
763 SLEEP DISORDER 4 0.0001
764 LYMPHOCYTE COUNT DECREASED 1 0.0001
765 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
766 VISUAL IMPAIRMENT 7 0.0001
767 THIRST 1 0.0001
768 GOUT 1 0.0001
769 OSTEOMYELITIS 1 0.0001
770 BONE DISORDER 1 0.0001
771 END STAGE RENAL DISEASE 1 0.0001
772 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
773 HAEMATOCHEZIA 3 0.0001
774 CHEST PAIN 10 0.0001
775 HEPATIC STEATOSIS 1 0.0001
776 HEPATIC FUNCTION ABNORMAL 2 0.0001
777 MIDDLE INSOMNIA 1 0.0001
778 EPISTAXIS 4 0.0001
779 HYPOAESTHESIA 8 0.0001
780 EYE PAIN 3 0.0001
781 DYSPNOEA EXERTIONAL 2 0.0001
782 HOT FLUSH 4 0.0001
783 COLITIS 2 0.0001
784 FOOT FRACTURE 1 0.0001
785 DYSPHAGIA 5 0.0001
786 GASTRIC ULCER 1 0.0001
787 PROTEINURIA 1 0.0001
788 LETHARGY 3 0.0001
789 HYPERTENSION 11 0.0001
790 HERNIA 1 0.0001
791 HAEMORRHOIDS 1 0.0001
792 VOMITING 24 0.0001
793 BLADDER CANCER 3 0.0001
794 WHEEZING 3 0.0001
795 BLOOD PRESSURE ABNORMAL 1 0.0001
796 PROSTATE CANCER 4 0.0000
797 EXTRA DOSE ADMINISTERED 2 0.0000
798 OEDEMA PERIPHERAL 6 0.0000
799 INSOMNIA 13 0.0000
800 PERITONITIS 1 0.0000
801 POLLAKIURIA 2 0.0000
802 KNEE ARTHROPLASTY 1 0.0000
803 PLATELET COUNT DECREASED 5 0.0000
804 FAECES DISCOLOURED 1 0.0000
805 AMNESIA 3 0.0000
806 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
807 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
808 STEVENS-JOHNSON SYNDROME 1 0.0000
809 TRANSAMINASES INCREASED 1 0.0000
810 PANCREATITIS ACUTE 1 0.0000
811 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 8 0.0000
812 HEPATIC ENZYME INCREASED 3 0.0000
813 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
814 TINNITUS 2 0.0000
815 MUSCLE TWITCHING 1 0.0000
816 PERICARDIAL EFFUSION 1 0.0000
817 GAIT DISTURBANCE 8 0.0000
818 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
819 JOINT SWELLING 5 0.0000
820 MENTAL IMPAIRMENT 1 0.0000
821 FIBROMYALGIA 1 0.0000
822 INJECTION SITE URTICARIA 1 0.0000
823 AGEUSIA 1 0.0000
824 HYPOPHAGIA 1 0.0000
825 HAEMORRHAGE 4 0.0000
826 JOINT STIFFNESS 1 0.0000
827 GASTRITIS 1 0.0000
828 PANCREATITIS 2 0.0000
829 DEPRESSED MOOD 2 0.0000
830 BREAST CANCER FEMALE 1 0.0000
831 MENSTRUATION IRREGULAR 1 0.0000
832 DYSPNOEA 21 0.0000
833 FREQUENT BOWEL MOVEMENTS 1 0.0000
834 LIMB INJURY 1 0.0000
835 PNEUMONITIS 1 0.0000
836 ANAPHYLACTIC REACTION 2 0.0000
837 DIZZINESS 18 0.0000
838 FEELING COLD 1 0.0000
839 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
840 FLATULENCE 2 0.0000
841 ANGINA PECTORIS 1 0.0000
842 DEATH 30 0.0000
843 MYOCARDIAL INFARCTION 6 0.0000
844 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
845 MUSCULOSKELETAL STIFFNESS 3 0.0000
846 DYSPHONIA 2 0.0000
847 BONE PAIN 2 0.0000
848 SURGERY 2 0.0000
849 ASCITES 1 0.0000
850 LABORATORY TEST ABNORMAL 1 0.0000
851 PREMATURE BABY 1 0.0000
852 HEPATIC FAILURE 1 0.0000
853 APHASIA 1 0.0000
854 LACRIMATION INCREASED 1 0.0000
855 ILL-DEFINED DISORDER 2 0.0000
856 SUICIDAL IDEATION 3 0.0000
857 EPILEPSY 1 0.0000
858 FEELING HOT 2 0.0000
859 FEMUR FRACTURE 1 0.0000
860 BREAST CANCER 3 0.0000
861 DRUG-INDUCED LIVER INJURY 1 0.0000
862 NEUROPATHY PERIPHERAL 3 0.0000
863 HYPOTHYROIDISM 1 0.0000
864 INTENTIONAL OVERDOSE 2 0.0000
865 DEPRESSION 7 0.0000
866 RENAL FAILURE 4 0.0000
867 SOMNOLENCE 6 0.0000
868 TYPE 2 DIABETES MELLITUS 1 0.0000
869 ANGER 1 0.0000
870 FEELING ABNORMAL 7 0.0000
871 GASTRIC DISORDER 1 0.0000
872 MEMORY IMPAIRMENT 4 0.0000
873 HYPERKALAEMIA 1 0.0000
874 MOBILITY DECREASED 2 0.0000
875 C-REACTIVE PROTEIN INCREASED 1 0.0000
876 ACCIDENTAL OVERDOSE 1 0.0000
877 FALL 9 0.0000
878 DYSARTHRIA 1 0.0000
879 ASTHMA 3 0.0000
880 SEIZURE 3 0.0000
881 ABDOMINAL PAIN 6 0.0000
882 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
883 DISORIENTATION 1 0.0000
884 CARDIAC FAILURE 2 0.0000
885 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
886 ASTHENIA 9 0.0000
887 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
888 ROAD TRAFFIC ACCIDENT 1 0.0000
889 LOSS OF CONSCIOUSNESS 3 0.0000
890 SEPTIC SHOCK 1 0.0000
891 PULMONARY OEDEMA 1 0.0000
892 VISION BLURRED 3 0.0000
893 ANXIETY 6 0.0000
894 PULMONARY EMBOLISM 2 0.0000
895 DISEASE RECURRENCE 1 0.0000
896 COMA 1 0.0000
897 COLORECTAL CANCER 1 0.0000
898 DYSPEPSIA 2 0.0000
899 LEUKOPENIA 1 0.0000
900 AGGRESSION 1 0.0000
901 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000
902 INJECTION SITE PAIN 6 0.0000
903 ABDOMINAL DISTENSION 2 0.0000
904 NERVOUSNESS 1 0.0000
905 DRUG INTERACTION 3 0.0000
906 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
907 CONFUSIONAL STATE 3 0.0000
908 DISTURBANCE IN ATTENTION 1 0.0000
909 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
910 OEDEMA 1 0.0000
911 TREMOR 3 0.0000
912 RHEUMATOID ARTHRITIS 2 0.0000
913 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
914 DISEASE PROGRESSION 2 0.0000
915 CATARACT 1 0.0000
916 NO ADVERSE EVENT 3 0.0000
917 SUICIDE ATTEMPT 1 0.0000
918 PLEURAL EFFUSION 1 0.0000
919 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
920 BLOOD GLUCOSE INCREASED 3 0.0000
921 INJECTION SITE PRURITUS 1 0.0000
922 INJECTION SITE REACTION 1 0.0000
923 INJURY 1 0.0000
924 RESPIRATORY FAILURE 1 0.0000
925 CHRONIC KIDNEY DISEASE 1 0.0000
926 ACUTE KIDNEY INJURY 2 0.0000
927 INJECTION SITE SWELLING 1 0.0000
928 DRUG DOSE OMISSION BY DEVICE 1 0.0000
929 INJECTION SITE BRUISING 1 0.0000
930 INJECTION SITE HAEMORRHAGE 1 0.0000
931 DRY MOUTH 1 0.0000
932 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
933 CARDIAC ARREST 1 0.0000
934 TACHYCARDIA 1 0.0000
935 ATRIAL FIBRILLATION 1 0.0000
936 SYNCOPE 1 0.0000
937 HYPOTENSION 2 0.0000
938 HAEMOGLOBIN DECREASED 1 0.0000
939 THROMBOCYTOPENIA 1 0.0000
940 INCORRECT DOSE ADMINISTERED 2 0.0000
941 EMOTIONAL DISTRESS 1 0.0000
942 INJECTION SITE ERYTHEMA 1 0.0000
943 HYPERHIDROSIS 1 0.0000
944 NEUTROPENIA 1 0.0000
945 DRUG DEPENDENCE 1 0.0000
946 ANAEMIA 1 0.0000
947 OVERDOSE 1 0.0000